Hospira advanced both its oncology and generic injectables pharmaceutical lines with two successive deals. The first was with ChemGenex Pharmaceuticals Limited, for the leukaemia drug, Omapro™, followed by acquiring the beta-lactam antibiotics manufacturing plant of Indian chemicals and pharma giant, Orchid.